Views & Analysis Real-world data – optimising your strategy for market access... The points to consider in preparing an effective data strategy.
Views & Analysis Keeping ahead of the curve Jon Williams, President of Evidera, is well-placed to offer his views on the issues impacting access to therapies.
Views & Analysis The case for blockchain in healthcare Blockchain is the tool needed to manage the vast quantities of data swamping healthcare systems.
Views & Analysis Expanding data sources: faster drug development? Using advanced technology and the skills of the data scientist to manage data from diverse sources.
Views & Analysis Patient personas can help drive behaviour change Creating patient personas from large data sets can drive greater understanding of patients' behaviours.
Views & Analysis Five questions: How are data and analytics transforming Medi... How big data and patient centricity are changing the Medical Affairs function.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
